MetLife (MET) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

MET Stock Forecast


MetLife stock forecast is as follows: an average price target of $87.46 (represents a 11.33% upside from MET’s last price of $78.56) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

MET Price Target


The average price target for MetLife (MET) is $87.46 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $145.00 to $74.00. This represents a potential 11.33% upside from MET's last price of $78.56.

MET Analyst Ratings


Buy

According to 11 Wall Street analysts, MetLife's rating consensus is 'Buy'. The analyst rating breakdown for MET stock is 0 'Strong Buy' (0.00%), 11 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

MetLife Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 02, 2024John BarnidgePiper Sandler$92.00$81.7812.50%17.11%
Sep 04, 2024Alex ScottBarclays$91.00$77.5217.39%15.84%
Aug 01, 2024Joshua ShankerBank of America Securities$96.00$76.8524.92%22.20%
Jul 10, 2024Bob HuangMorgan Stanley$83.00$69.9218.71%5.65%
May 22, 2024Kevin HealArgus Research$80.00$73.159.36%1.83%
May 06, 2024John BarnidgePiper Sandler$82.00$70.9415.60%4.38%
Mar 13, 2024Catherine SeifertCFRA$77.00$72.675.96%-1.99%
Jan 08, 2024Alex ScottGoldman Sachs$80.00$68.9216.08%1.83%
Sep 14, 2023Brett LinzeyMizuho Securities$145.00$63.79127.31%84.57%
Feb 02, 2023-Morgan Stanley$90.00$72.6823.83%14.56%
Row per page
Go to

The latest MetLife stock forecast, released on Oct 02, 2024 by John Barnidge from Piper Sandler, set a price target of $92.00, which represents a 12.50% increase from the stock price at the time of the forecast ($81.78), and a 17.11% increase from MET last price ($78.56).

MetLife Price Target by Period


1M3M12M
# Anlaysts-28
Avg Price Target-$91.50$85.13
Last Closing Price$78.56$78.56$78.56
Upside/Downside-100.00%16.47%8.36%

In the current month, the average price target of MetLife stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to MetLife's last price of $78.56. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 08, 2024Cowen & Co.-BuyInitialise
Oct 02, 2024Piper SandlerOverweightOverweightHold
Sep 27, 2024JefferiesBuyBuyHold
Sep 26, 2024Evercore ISIOutperformOutperformHold
Aug 12, 2024Wells FargoOverweightOverweightHold
Jul 23, 2024CitigroupBuyBuyHold
Jul 18, 2024JefferiesBuyBuyHold
Jul 10, 2024Morgan StanleyOverweightOverweightHold
May 06, 2024Piper SandlerOverweightOverweightHold
Apr 11, 2024CitigroupUnderperformUnderperformHold
Row per page
Go to

MetLife's last stock rating was published by Cowen & Co. on Oct 08, 2024. The company Initialise its MET rating from "null" to "Buy".

MetLife Financial Forecast


MetLife Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue-----------------$15.87B$16.62B$15.39B$16.32B$22.27B$15.56B$1.16B$19.17B$15.23B$15.86B$14.28B$19.71B$15.44B
Avg Forecast$22.53B$21.86B$21.37B$19.73B$20.55B$20.23B$19.61B$19.05B$20.05B$19.65B$18.99B$18.31B$19.26B$18.66B$18.57B$17.73B$18.46B$17.68B$16.91B$16.84B$17.22B$20.58B$16.04B$16.78B$17.67B$16.28B$15.84B$16.03B$16.21B$16.00B
High Forecast$23.77B$23.06B$22.55B$20.82B$21.68B$21.34B$20.68B$20.09B$21.15B$20.73B$20.03B$18.80B$20.90B$18.70B$18.57B$17.73B$19.42B$18.62B$17.84B$17.76B$18.16B$20.58B$16.04B$16.78B$17.67B$16.28B$15.84B$16.03B$16.21B$16.00B
Low Forecast$21.51B$20.86B$20.40B$18.84B$19.62B$19.31B$18.71B$18.18B$19.14B$18.76B$18.12B$17.78B$18.07B$18.62B$18.57B$17.73B$17.72B$16.71B$16.14B$16.07B$16.43B$20.58B$16.04B$16.78B$17.67B$16.28B$15.84B$16.03B$16.21B$16.00B
# Analysts222222221114544456334444333333
Surprise %-----------------0.90%0.98%0.91%0.95%1.08%0.97%0.07%1.08%0.94%1.00%0.89%1.22%0.96%

MetLife's average Quarter revenue forecast for Dec 23 based on 5 analysts is $18.46B, with a low forecast of $17.72B, and a high forecast of $19.42B. MET's average Quarter revenue forecast represents a 16.33% increase compared to the company's last Quarter revenue of $15.87B (Sep 23).

MetLife EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts222222221114544456334444333333
EBITDA-----------------$-78.00M$-197.00M$507.00M$1.97B$589.00M$218.00M$935.00M$1.52B$2.28B$4.71B$514.00M$394.00M$1.15B
Avg Forecast$1.53B$1.49B$1.46B$1.34B$1.40B$1.38B$1.33B$1.30B$1.37B$1.34B$1.29B$1.25B$1.31B$1.27B$1.26B$1.11B$1.26B$1.20B$1.15B$874.54M$965.93M$1.40B$1.09B$691.33M$1.20B$1.11B$1.08B$317.81M$1.10B$1.09B
High Forecast$1.62B$1.57B$1.53B$1.42B$1.48B$1.45B$1.41B$1.37B$1.44B$1.41B$1.36B$1.28B$1.42B$1.27B$1.26B$1.33B$1.32B$1.27B$1.21B$1.05B$1.16B$1.40B$1.09B$829.60M$1.20B$1.11B$1.08B$381.37M$1.10B$1.09B
Low Forecast$1.46B$1.42B$1.39B$1.28B$1.34B$1.31B$1.27B$1.24B$1.30B$1.28B$1.23B$1.21B$1.23B$1.27B$1.26B$885.03M$1.21B$1.14B$1.10B$699.63M$772.74M$1.40B$1.09B$553.07M$1.20B$1.11B$1.08B$254.25M$1.10B$1.09B
Surprise %------------------0.06%-0.17%0.58%2.04%0.42%0.20%1.35%1.27%2.05%4.37%1.62%0.36%1.05%

3 analysts predict MET's average Quarter EBITDA for Jun 23 to be $1.15B, with a high of $1.21B and a low of $1.10B. This is 127.12% upper than MetLife's previous annual EBITDA (Mar 23) of $507.00M.

MetLife Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts222222221114544456334444333333
Net Income-----------------$489.00M$402.00M$80.00M$1.34B$395.00M$132.00M$669.00M$1.21B$1.58B$3.41B$358.00M$158.00M$706.00M
Avg Forecast$2.23B$2.20B$2.14B$1.88B$1.98B$1.96B$1.91B$1.69B$1.80B$1.77B$1.75B$1.52B$1.61B$1.53B$1.48B$791.56M$1.32B$1.37B$1.34B$625.74M$763.74M$843.50M$1.04B$494.65M$1.05B$1.24B$1.20B$221.35M$1.09B$1.15B
High Forecast$2.39B$2.35B$2.29B$2.02B$2.13B$2.10B$2.05B$1.81B$1.93B$1.90B$1.87B$1.56B$1.70B$1.56B$1.48B$949.87M$1.42B$1.52B$1.43B$750.89M$916.49M$876.18M$1.04B$593.59M$1.05B$1.24B$1.20B$265.62M$1.09B$1.15B
Low Forecast$2.10B$2.07B$2.01B$1.77B$1.87B$1.85B$1.80B$1.59B$1.69B$1.67B$1.65B$1.48B$1.45B$1.49B$1.48B$633.25M$1.18B$1.24B$1.26B$500.59M$610.99M$810.83M$1.04B$395.72M$1.05B$1.24B$1.20B$177.08M$1.09B$1.15B
Surprise %-----------------0.36%0.30%0.13%1.76%0.47%0.13%1.35%1.15%1.28%2.83%1.62%0.15%0.61%

MetLife's average Quarter net income forecast for Dec 23 is $1.32B, with a range of $1.18B to $1.42B. MET's average Quarter net income forecast represents a 170.66% increase compared to the company's last Quarter net income of $489.00M (Sep 23).

MetLife SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts222222221114544456334444333333
SG&A-------------------$1.48B$1.57B$1.45B-$1.43B$1.65B$1.40B$1.30B$1.42B$1.56B$1.38B
Avg Forecast$1.97B$1.91B$1.87B$1.73B$1.80B$1.77B$1.72B$1.67B$1.76B$1.72B$1.66B$1.60B$1.69B$1.63B$1.63B$1.70B$1.62B$1.55B$1.48B$1.34B$1.04B$1.80B$1.40B$1.06B$1.55B$1.43B$1.39B$877.37M$1.42B$1.40B
High Forecast$2.08B$2.02B$1.97B$1.82B$1.90B$1.87B$1.81B$1.76B$1.85B$1.82B$1.75B$1.65B$1.83B$1.64B$1.63B$2.03B$1.70B$1.63B$1.56B$1.61B$1.25B$1.80B$1.40B$1.27B$1.55B$1.43B$1.39B$1.05B$1.42B$1.40B
Low Forecast$1.88B$1.83B$1.79B$1.65B$1.72B$1.69B$1.64B$1.59B$1.68B$1.64B$1.59B$1.56B$1.58B$1.63B$1.63B$1.36B$1.55B$1.46B$1.41B$1.07B$834.09M$1.80B$1.40B$847.64M$1.55B$1.43B$1.39B$701.89M$1.42B$1.40B
Surprise %-------------------1.10%1.50%0.81%-1.35%1.06%0.98%0.94%1.62%1.10%0.99%

MetLife's average Quarter SG&A projection for Jun 23 is $1.48B, based on 3 Wall Street analysts, with a range of $1.41B to $1.56B. The forecast indicates a 0.12% rise compared to MET last annual SG&A of $1.48B (Mar 23).

MetLife EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts222222221114544456334444333333
EPS-----------------$0.56$0.48$0.02$1.69$0.42$0.13$0.74$1.44$1.78$3.85$0.33$0.14$0.70
Avg Forecast$3.17$3.12$3.04$2.67$2.82$2.79$2.71$2.40$2.56$2.52$2.49$2.16$2.29$2.17$2.10$1.84$1.88$1.94$1.90$1.81$1.67$1.18$1.45$1.65$1.47$1.74$1.68$1.53$1.52$1.61
High Forecast$3.40$3.35$3.25$2.87$3.02$2.99$2.91$2.57$2.74$2.70$2.66$2.22$2.42$2.22$2.10$1.84$2.02$2.16$2.04$1.94$1.79$1.23$1.45$1.65$1.47$1.74$1.68$1.53$1.52$1.61
Low Forecast$2.98$2.94$2.86$2.52$2.65$2.62$2.55$2.26$2.41$2.37$2.34$2.10$2.06$2.12$2.10$1.84$1.68$1.77$1.79$1.71$1.57$1.13$1.45$1.65$1.47$1.74$1.68$1.53$1.52$1.61
Surprise %-----------------0.29%0.25%0.01%1.01%0.36%0.09%0.45%0.98%1.02%2.29%0.22%0.09%0.43%

According to 5 Wall Street analysts, MetLife's projected average Quarter EPS for Dec 23 is $1.88, with a low estimate of $1.68 and a high estimate of $2.02. This represents a 235.86% increase compared to MET previous annual EPS of $0.56 (Sep 23).

MetLife Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
LNCLincoln National$32.91$52.3659.10%Hold
METMetLife$78.56$87.4611.33%Buy
UNMUnum Group$64.08$67.405.18%Buy
GLGlobe Life$103.49$108.254.60%Hold
PRUPrudential Financial$120.66$116.00-3.86%Buy
JXNJackson Financial$98.20$92.67-5.63%Hold
AFLAflac$104.51$93.11-10.91%Hold
MFCManulife Financial$29.70$25.86-12.93%Buy
CNOCNO Financial Group$35.75$31.00-13.29%Hold

MET Forecast FAQ


Yes, according to 11 Wall Street analysts, MetLife (MET) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 100.00% of MET's total ratings.

MetLife (MET) average price target is $87.46 with a range of $74 to $145, implying a 11.33% from its last price of $78.56. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for MET stock, the company can go up by 11.33% (from the last price of $78.56 to the average price target of $87.46), up by 84.57% based on the highest stock price target, and down by -5.80% based on the lowest stock price target.

MET's highest twelve months analyst stock price target of $145 supports the claim that MetLife can reach $120 in the near future.

MetLife's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $79.44B (high $83.8B, low $75.82B), average EBITDA is $5.41B (high $5.71B, low $5.16B), average net income is $7.55B (high $8.09B, low $7.1B), average SG&A $6.95B (high $7.34B, low $6.64B), and average EPS is $10.73 (high $11.49, low $10.09). MET's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $85.5B (high $90.19B, low $81.6B), average EBITDA is $5.82B (high $6.14B, low $5.56B), average net income is $8.45B (high $9.05B, low $7.95B), average SG&A $7.49B (high $7.9B, low $7.14B), and average EPS is $12 (high $12.86, low $11.29).

Based on MetLife's last annual report (Dec 2022), the company's revenue was $69.9B, which missed the average analysts forecast of $70.61B by -1.01%. Apple's EBITDA was $3.78B, missing the average prediction of $4.15B by -8.97%. The company's net income was $2.54B, missing the average estimation of $3.14B by -19.10%. Apple's SG&A was $5.89B, beating the average forecast of $5.31B by 10.98%. Lastly, the company's EPS was $2.93, missing the average prediction of $5.95 by -50.73%. In terms of the last quarterly report (Sep 2023), MetLife's revenue was $15.87B, missing the average analysts' forecast of $17.68B by -10.26%. The company's EBITDA was $-78M, missing the average prediction of $1.2B by -106.48%. MetLife's net income was $489M, missing the average estimation of $1.37B by -64.26%. The company's SG&A was $0, missing the average forecast of $1.55B by -100.00%. Lastly, the company's EPS was $0.56, missing the average prediction of $1.94 by -71.19%